Clinical Trial Update: NICU Antibiotics and Outcomes (NANO) Follow-up Study [Phase 3]

View source ↗

Summary

Phase 3 follow-up study assessing NICU antibiotic exposure and neurodevelopmental outcomes in premature birth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurodevelopmental Disorders
• Premature Birth

Snippet

Sponsor: Sharp HealthCare | Conditions: Premature Birth, Antibiotics | Phase 3 | Status: NOT_YET_RECRUITING